Real-time enrollment status for this glioblastoma clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 2:01 PM UTC
| NCT Number | NCT06336291 |
| Recruiting Status | Recruiting |
| Condition | Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 90 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Philogen S.p.A. |
| Last Updated on CT.gov | January 24, 2025 (Jan 24, 2025) |
As of March 2, 2026: Clinical trial NCT06336291 is currently recruiting participants. This clinical trial study for glioblastoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by Philogen S.p.A.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06336291 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06336291 was last updated Jan 24, 2025 (January 24, 2025). HelloStudys verifies this status automatically.